Evaluation of disease activity indices in Korean patients with rheumatoid arthritis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, So-Yeon | - |
dc.contributor.author | Lee, Hyeseon | - |
dc.contributor.author | Cho, Soo-Kyung | - |
dc.contributor.author | Choi, Chan-Bum | - |
dc.contributor.author | Sung, Yoon-Kyoung | - |
dc.contributor.author | Bae, Sang-Cheol | - |
dc.date.accessioned | 2021-08-02T19:30:27Z | - |
dc.date.available | 2021-08-02T19:30:27Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2012-02 | - |
dc.identifier.issn | 0172-8172 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/27600 | - |
dc.description.abstract | The aim of this study is to examine the validity of the rheumatoid arthritis (RA), disease activity score (DAS), 28-C-reactive protein (CRP), the simplified disease activity index (SDAI), and the clinical disease activity index (CDAI) against the DAS28-erythrocyte sedimentation rate (ESR) and determine cut-off values for each tool in Korean patients with RA. A total of 223 RA patients were consecutively recruited from the Hanyang University Hospital for Rheumatic Diseases in Seoul, Korea. DAS28-CRP, SDAI, and CDAI were measured and compared with DAS28-ESR. The correlation coefficients of DAS28-ESR with DAS28-CRP, SDAI, and CDAI were 0.93, 0.85, and 0.84, demonstrating strong linear relationships. The cut-off values of DAS28-CRP classifying RA patients into four categories of disease activity were defined as 2.19, 2.60, and 4.07. SDAI cut-off values were defined as 3.75, 7.50, and 16.88. CDAI cut-off values were defined as 3.62, 7.38, and 16.50. DAS28-CRP, SDAI, and CDAI are valid and sensitive assessment indices of disease activity that are comparable to DAS28-ESR. The cut-off values of each tool derived in this study might be useful for routine monitoring and therapeutic decision-making in Korean RA patients. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | SPRINGER HEIDELBERG | - |
dc.title | Evaluation of disease activity indices in Korean patients with rheumatoid arthritis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cho, Soo-Kyung | - |
dc.contributor.affiliatedAuthor | Choi, Chan-Bum | - |
dc.contributor.affiliatedAuthor | Sung, Yoon-Kyoung | - |
dc.contributor.affiliatedAuthor | Bae, Sang-Cheol | - |
dc.identifier.doi | 10.1007/s00296-011-1798-x | - |
dc.identifier.scopusid | 2-s2.0-84863158427 | - |
dc.identifier.wosid | 000299507900048 | - |
dc.identifier.bibliographicCitation | RHEUMATOLOGY INTERNATIONAL, v.32, no.2, pp.545 - 549 | - |
dc.relation.isPartOf | RHEUMATOLOGY INTERNATIONAL | - |
dc.citation.title | RHEUMATOLOGY INTERNATIONAL | - |
dc.citation.volume | 32 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 545 | - |
dc.citation.endPage | 549 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Rheumatology | - |
dc.relation.journalWebOfScienceCategory | Rheumatology | - |
dc.subject.keywordPlus | C-REACTIVE PROTEIN | - |
dc.subject.keywordPlus | ERYTHROCYTE SEDIMENTATION-RATE | - |
dc.subject.keywordPlus | ACTIVITY SCORE | - |
dc.subject.keywordPlus | CRITERIA | - |
dc.subject.keywordPlus | VALIDATION | - |
dc.subject.keywordPlus | DAS28 | - |
dc.subject.keywordAuthor | Disease activity score | - |
dc.subject.keywordAuthor | ESR | - |
dc.subject.keywordAuthor | CRP | - |
dc.subject.keywordAuthor | Disease activity index | - |
dc.subject.keywordAuthor | Rheumatoid arthritis | - |
dc.identifier.url | https://link.springer.com/article/10.1007%2Fs00296-011-1798-x | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.